Serving hundreds of leading biopharmaceutical companies globally:

Generated: October 17, 2018

DrugPatentWatch Database Preview

Hikma Company Profile

« Back to Dashboard

What is the competitive landscape for HIKMA, and when can generic versions of HIKMA drugs launch?

HIKMA has one hundred and fifty-seven approved drugs.

There are five US patents protecting HIKMA drugs. There are two tentative approvals on HIKMA drugs.

Summary for Hikma

US Patents:	5
Tradenames:	118
Ingredients:	111
NDAs:	157
Patent Litigation for Hikma:	See patent lawsuits for Hikma
PTAB Cases with Hikma as petitioner:	See PTAB cases with Hikma as petitioner

Drugs and US Patents for Hikma

+ Get email alerts for changes to this table

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hikma Pharms	FLURAZEPAM HYDROCHLORIDE	flurazepam hydrochloride	CAPSULE;ORAL	071108-001	Dec 8, 1986		DISCN	No	No		➤ Sign Up				➤ Sign Up
Hikma Pharms	DONEPEZIL HYDROCHLORIDE	donepezil hydrochloride	TABLET;ORAL	090247-001	May 31, 2011		DISCN	No	No		➤ Sign Up				➤ Sign Up
Hikma Intl Pharms	DOXYCYCLINE HYCLATE	doxycycline hyclate	CAPSULE;ORAL	062396-002	Nov 7, 1984	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Hikma Pharms	DONEPEZIL HYDROCHLORIDE	donepezil hydrochloride	TABLET;ORAL	090247-002	May 31, 2011		DISCN	No	No		➤ Sign Up				➤ Sign Up
Hikma Farmaceutica	FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	fluconazole	INJECTABLE;INJECTION	078698-001	Jan 30, 2012	AP	RX	No	No		➤ Sign Up				➤ Sign Up
Hikma Pharms	AMOXICILLIN AND CLAVULANATE POTASSIUM	amoxicillin; clavulanate potassium	FOR SUSPENSION;ORAL	065373-001	Nov 9, 2007	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Hikma Farmaceutica	TERBUTALINE SULFATE	terbutaline sulfate	INJECTABLE;INJECTION	078630-001	May 20, 2009	AP	RX	No	No		➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Paragraph IV (Patent) Challenges for HIKMA drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Capsules	0.6 mg	➤ Subscribe	2016-06-10
➤ Subscribe	Injection	1 mg/mL, 50 mL vials	➤ Subscribe	2011-12-16
➤ Subscribe	Injection	100 mg/mL, 2.5 mL vials	➤ Subscribe	2007-09-24

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow

AstraZeneca

Cerilliant

Covington

Colorcon

Baxter

Deloitte

Fuji

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.